Antimicrobial Resistance News and Research

RSS

Multinational companies continue to manufacture unapproved formulations in India, research finds

Millions of unapproved antibiotics are being sold in India, according to a new study by researchers at Queen Mary University of London and Newcastle University.

5 Feb 2018

WHO's new surveillance data reveals widespread occurrence of antibiotic resistance

WHO's first release of surveillance data on antibiotic resistance reveals high levels of resistance to a number of serious bacterial infections in both high- and low-income countries.

29 Jan 2018

Scientists uncover genes responsible for drug resistance in Leprosy bacterium

In a new study, scientists have uncovered the genes responsible for antibiotic resistance in strains of M. leprae, the bacterium that causes leprosy.

26 Jan 2018

Genome analysis reveals leprosy's origin and drug resistance

Leprosy is an infectious disease with gruesome symptoms. It damages the skin, peripheral nerves, the upper respiratory tract, and the eyes.

24 Jan 2018

Guts of surfers more likely to be colonized by antibiotic-resistant bacteria, study reveals

Regular surfers and bodyboarders are three times more likely to have antibiotic resistant E. coli in their guts than non-surfers, new research has revealed.

15 Jan 2018

Study explores antibiotic use and UTIs among nursing home residents

In a Journal of the American Geriatrics Society study of nursing homes in the tropics, one in five residents had received antibiotics within the last 30 days.

10 Jan 2018

Edixomed develops revolutionary technology for tackling antimicrobial resistance

New results announced at the recent Wounds UK conference and Eurobiofilms 2017 congress, have provided the latest evidence that Edixomed, a UK biotechnology company, has developed a revolutionary new technology for tackling the enormous public health challenge of antimicrobial resistance (AMR).

22 Dec 2017

EPFL scientists create gold nanoparticles to combat all viruses

HIV, dengue, papillomavirus, herpes and Ebola - these are just some of the many viruses that kill millions of people every year, mostly children in developing countries. While drugs can be used against some viruses, there is currently no broad-spectrum treatment that is effective against several at the same time, in the same way that broad-spectrum antibiotics fight a range of bacteria.

18 Dec 2017

FDA announces new approach for sharing updates on antibiotics, antifungal drugs to physicians

Today the U.S. Food and Drug Administration is announcing a new approach to get critical updates regarding antibiotics and antifungal drugs to health care professionals as part of an overall effort to combat antimicrobial resistance.

14 Dec 2017

Tailor-made protein combats several kinds of pathogenic bacteria

As resistance to existing antibiotics increases, new approaches to serious bacterial infections are needed. Now researchers at Lund University in Sweden, together with colleagues at the University of Massachusetts Medical School in the US, have investigated one such alternative.

13 Dec 2017

1 in 10 medical products found to be substandard or falsified in low- and middle-income countries

An estimated 1 in 10 medical products circulating in low- and middle-income countries is either substandard or falsified, according to new research from the World Health Organization.

5 Dec 2017

Penn study: New dental material kills bacteria and resists biofilm growth

Dentists rely on composite materials to perform restorative procedures, such as filling cavities. Yet these materials, like tooth enamel, can be vulnerable to the growth of plaque, the sticky biofilm that leads to tooth decay.

5 Dec 2017

University of Bristol awarded grant to reduce antibacterial drug resistance in Thailand

The University of Bristol has been awarded a grant by the UK Research Councils and the Department of Health to lead an inter-disciplinary research project to tackle the growing threat of antibacterial drug resistance in Thailand.

16 Nov 2017

Breakthrough discovery could radically change approach to treating Klebsiella infections

Researchers at Queen's University Belfast together with the University of Vienna have discovered that treatment for the antibiotic-resistant bacteria Klebsiella pneumoniae could lie within our bodies' natural defenses.

14 Nov 2017

Vaccines in the Aging Population

The World Health Organisation marked World Pneumonia Day on November 12th to promote interventions to protect against, prevent and treat pneumonia. The condition is a worldwide killer affecting people of all ages, however the ‘aging population’ is at an increased risk.

From Pfizer, Inc. 13 Nov 2017

Leading organizations call for responsible use of antibiotics to combat rising drug resistance

In the lead-up to World Antibiotic Awareness Week (13-19 November 2017), the Food and Agriculture Organization of the United Nations, the World Health Organization and the World Organisation for Animal Health are together calling for responsible use of antibiotics in humans and animals to reduce the emergence of antibiotic resistance.

13 Nov 2017

Experts drive Neem Biotech’s efforts to counter effects of antimicrobial resistance on treatment of lung infections

Neem Biotech, the Welsh-based fundamental Research and Development arm of the Zaluvida group of life science companies, is pleased to present an interview with two thought leaders in the field of bacterially-caused chronic lung infections.

From Neem Biotech 9 Nov 2017

Antibiotic use in healthy farm animals needs to stop: World Health Organization

According to new advisory guidelines from the United Nations health agency WHO yesterday (7th November 2017), the farmers and the food industry need to stop the use of antibiotics among healthy farm animals routinely. At present many farmers use these antibiotics on healthy animals to make sure that they grow better and diseases are prevented in them.

7 Nov 2017

Scientists make significant advance towards creating commercially viable superbug-killing antibiotic

Scientists working to develop a 'game-changing' new antibiotic have made a significant advance towards creating commercially viable drug treatments by producing two simplified synthetic versions of the substance which are just as potent at killing superbugs like MRSA as its natural form.